AAOS: GLP-1 Receptor Agonist Use Increases Five-Year Risk for Osteoporosis

GLP-1 drugs linked to higher fracture risk, osteoporosis and gout, new studies suggest | Fox Wilmington WSFX-TV

close Video GLP-1 drugs require lifestyle change to work long term as expert warns of potential ‘danger’ Fox News senior medical analyst Dr. Marc Siegel discusses the benefits and risks of GLP-1 medications on ‘Fox & Friends Weekend.’ NEWYou can now listen to Fox News articles! GLP-1 medications such as Ozempic and Wegovy have transformed treatment for type 2 diabetes and obesity — but new research suggests doctors may need to pay closer atte…

GLP-1 drugs linked to higher fracture risk, osteoporosis and gout, new studies suggest

New research links GLP-1 drugs like Ozempic to higher fracture risk, osteoporosis and gout, prompting experts to urge bone health screening in older adults.

AAOS: GLP-1 receptor agonist use increases five-year risk for osteoporosis

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type 2 diabetes and obesity is independently associated with a significantly increased five-year risk for osteoporosis, gout, and osteomalacia compared with nonuse, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 2 to 6 in New Orleans.

GLP-1 Drugs May Raise the Risk of Osteoporosis and Gout, Study Suggests

Fact checked by Nick BlackmerOsteoporosis makes bones weak and prone to fractures.Credit: Thai Liang Lim / Getty ImagesNew research suggests prolonged GLP-1 use may be linked to a higher risk of osteoporosis and gout.Osteoporosis occurs when bones become weak, while gout is a type of inflammatory arthritis.The research, which hasn't been peer reviewed, only shows associations and does not prove causation.People who take GLP-1 medications for sev…

GLP-1 drugs linked to higher fracture risk, osteoporosis and gout, new studies suggest – Democratic Accent

GLP-1 medications such as Ozempic and Wegovy have transformed treatment for type 2 diabetes and obesity — but new research suggests doctors may need to pay closer attention to bone health, especially in older patients taking the drugs. Older adults with type 2 diabetes who started GLP-1s had an 11% higher risk of fragility fractures compared to those taking other diabetes medications, a study published in February in the Journal of Clinical Endo…

Popular weight‑loss and diabetes drugs may increase risks of bone and joint problems

Drugs known as GLP‑1 receptor agonists have become very popular in recent years. These medicines are widely used to treat type 2 diabetes and, more recently, to help people lose weight. Well‑known examples include semaglutide, liraglutide, dulaglutide, and exenatide. Some of these drugs are sold under well‑known brand names that have received enormous attention because […] The post Popular weight‑loss and diabetes drugs may increase risks of bon…